Amundi
VCYT icon

Amundi’s Veracyte VCYT Stock Holding History

Amundi’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$391K Sell
12,124
-116,588
-91% -$4.32M ﹤0.01% 1643
2025
Q4 		$5.42M Sell
128,712
-33,025
-20% -$1.33M ﹤0.01% 1019
2025
Q3 		$5.83M Buy
+161,737
New +$4.64M ﹤0.01% 932
2023
Q3 		– Sell
-3,500
Closed -$87.2K – 2067
2023
Q2 		$87.2K Hold
3,500
– – ﹤0.01% 1801
2023
Q1 		$75.2K Hold
3,500
– – ﹤0.01% 1814
2022
Q4 		$88.3K Buy
+3,500
New +$81.3K ﹤0.01% 1631

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Amundi's VCYT Position: Q1 2026 in Review

Amundi reduced its Veracyte (VCYT) stake by 91% in Q1 2026, selling an estimated $4.32M and leaving 12,124 shares worth $391K. The position accounts for ﹤0.01% of the portfolio, ranked #1643.

Amundi first reported a position in VCYT in Q4 2022 and has held it in 6 quarters since. The position peaked at $5.83M in Q3 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Amundi held 12,124 shares of Veracyte worth $391K as of Q1 2026.
  • Amundi sold 116,588 Veracyte shares in Q1 2026, an estimated $4.32M.
  • Veracyte made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1643 holding.
  • Amundi first reported a position in Veracyte in Q4 2022 and has held it in 6 quarters since.
  • Amundi's Veracyte position peaked at $5.83M in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.